Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2023

Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]

Schedule of Available-for-Sale Marketable Securities

The following is a summary of available-for-sale marketable securities, as of December 31, 2023 and 2022, respectively (in thousands):

	December 31, 2023
	Amortized Cost		Unrealized Gain		Unrealized Losses			Fair Value
Cash equivalents:
Corporate securities (1)	$	1,213	$	—	$	(1	)	$	1,212
Total cash equivalents		1,213		—		(1	)		1,212
Marketable securities:
Corporate securities (1)	$	199,084	$	115	$	(819	)	$	198,380
U.S. treasury and agency securities		30,404		25		(48	)		30,381
Total marketable securities	$	229,488	$	140	$	(867	)	$	228,761
(1) Comprised primarily of corporate bonds and commercial paper

	December 31, 2022
	Amortized Cost		Unrealized Gain		Unrealized Losses			Fair Value
Marketable securities:
Corporate securities (1)	$	184,321	$	75	$	(2,344	)	$	182,052
U.S. treasury and agency securities		34,071		3		(200	)		33,874
Total marketable securities	$	218,392	$	78	$	(2,544	)	$	215,926
(1) Comprised primarily of corporate bonds and commercial paper

Schedule of Fair Values of Available-for-Sale Marketable Securities

As of December 31, 2023, the fair values of available-for-sale financial instruments, by remaining contractual maturity, were as follows (in thousands):

Due within one year	$	164,921
Due in one to five years		65,052
Total	$	229,973